Statistik Asas
| LEI | 549300HFRIPQDYU3GU60 |
| CIK | 1533615 |
SEC Filings
All companies that sell securities in the United States must register with the Securities and Exchange Commission (SEC) and file reports on a regular basis.
These reports include company annual reports (10K, 10Q), news updates (8K), investor presentations (found in 8Ks), insider trades (form 4), ownership reports (13D, and 13G), and reports related to the specific securities sold, such as registration statements and prospectus. This page shows recent SEC filings related to Global Medical REIT Inc.
SEC Filings (Chronological Order)
Halaman ini menyediakan senarai kronologi lengkap bagi Pemfailan SEC, tidak termasuk pemfailan pemilikan yang kami sediakan di tempat lain.
| August 6, 2025 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 FORM 10-Q Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 FORM 10-Q ☑ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended June 30, 2025 or ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to . |
|
| August 5, 2025 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(D) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of earliest event reported): August 5, 2025 (August 5, 2025) Global Medical REIT Inc. (Exact name of registrant as specified in its charter) Maryland 001-37815 46-4757266 (State or Other Jurisdiction of Incorpora |
|
| August 5, 2025 |
Exhibit 99.1 Global Medical REIT Announces Second Quarter 2025 Financial Results – Appoints Mark Decker, Jr. as Chief Executive Officer – – Completes Acquisition of Previously Announced $69.6 Million Five-Property Medical Portfolio – – Reaffirms Full Year 2025 AFFO Guidance – Bethesda, MD – August 5, 2025 – (BUSINESS WIRE) – Global Medical REIT Inc. (NYSE: GMRE) (the “Company” or “GMRE”), today an |
|
| August 5, 2025 |
Exhibit 99.2 SECOND QUARTER 2025 EARNINGS SUPPLEMENTAL www.globalmedicalreit.com NYSE: GMRE Atrium Health – Winston-Salem, NC Forward-Looking Statements Certain statements contained herein may be considered “forward-looking statements” within the meaning of the Private Securities Litigation Reform Act of 1995, and it is the Company’s intent that any such statements be protected by the safe harbor |
|
| June 23, 2025 |
GLOBAL MEDICAL REIT APPOINTS MARK DECKER, JR. AS CEO EX-99.1 3 tm2518616d1ex99-1.htm EXHIBIT 99.1 Exhibit 99.1 GLOBAL MEDICAL REIT APPOINTS MARK DECKER, JR. AS CEO Bethesda, MD – June 23, 2025 – (BUSINESS WIRE) – Global Medical REIT Inc. (NYSE: GMRE) (the “Company” or “GMRE”), today announced that Mark Decker, Jr. has been appointed as the Company’s Chief Executive Officer and President, effective immediately. Mr. Decker, who will join the Board of |
|
| June 23, 2025 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(D) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of earliest event reported): June 23, 2025 (June 20, 2025) Global Medical REIT Inc. (Exact name of registrant as specified in its charter) Maryland 001-37815 46-4757266 (State or Other Jurisdiction of Incorporati |
|
| June 23, 2025 |
EX-10.1 2 tm2518616d1ex10-1.htm EXHIBIT 10.1 Exhibit 10.1 EMPLOYMENT AGREEMENT This Employment Agreement (“Agreement”) is made and entered into by and between Inter-American Management LLC, a Delaware limited liability company (the “Company”), and Mark Decker (“Employee”), effective as of June 23, 2025 (the “Effective Date”). WHEREAS, the Company desires to employ Employee on the terms and conditi |
|
| May 28, 2025 |
GLOBAL MEDICAL REIT INC. BOARD DECLARES 2025 SECOND QUARTER COMMON AND PREFERRED DIVIDENDS Exhibit 99.2 GLOBAL MEDICAL REIT INC. BOARD DECLARES 2025 SECOND QUARTER COMMON AND PREFERRED DIVIDENDS May 28, 2025 4:05pm EST BETHESDA, Md.-(BUSINESS WIRE)- Global Medical REIT Inc. (NYSE: GMRE) (the “Company” or “GMRE”), a net-lease medical real estate investment trust (REIT) that acquires healthcare facilities and leases those facilities to physician groups and regional and national healthcare |
|
| May 28, 2025 |
Regulation FD Disclosure, Financial Statements and Exhibits, Other Events UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(D) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of earliest event reported): May 28, 2025 (May 28, 2025) Global Medical REIT Inc. (Exact name of registrant as specified in its charter) Maryland 001-37815 46-4757266 (State or Other Jurisdiction of Incorporation |
|
| May 28, 2025 |
Investor Presentation May 2025 Exhibit 99.1 Investor Presentation May 2025 Our primary mission is to attain earnings growth with a well covered dividend by maximizing the investment spread in our healthcare real estate assets. Our strategies to achieve this mission are as follows: • Asset Type - primarily invest in off - campus, out - patient medical facilities, and post - acute, in - patient medical facilities; • Asset Yield - |
|
| May 15, 2025 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of earliest event reported): May 15, 2025 (May 14, 2025) Global Medical REIT Inc. (Exact name of registrant as specified in its charter) Maryland 001-37815 46-4757266 (State or other jurisdiction of incorporation |
|
| May 8, 2025 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 FORM 10-Q Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 FORM 10-Q ☑ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended March 31, 2025 or ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to . |
|
| May 7, 2025 |
Exhibit 99.1 Global Medical REIT Announces First Quarter 2025 Financial Results – Completes Acquisition of Previously Announced $69.6 Million Five-Property Medical Portfolio – – Reaffirms Full Year 2025 AFFO Guidance – Bethesda, MD – May 7, 2025 – (BUSINESS WIRE) – Global Medical REIT Inc. (NYSE: GMRE) (the “Company” or “GMRE”), a net-lease medical real estate investment trust (REIT) that acquires |
|
| May 7, 2025 |
Exhibit 99.2 FIRST QUARTER 2025 EARNINGS SUPPLEMENTAL www.globalmedicalreit.com NYSE: GMRE Atrium Health – Winston - Salem, NC Forward - Looking Statements Certain statements contained herein may be considered “forward - looking statements” within the meaning of the Private Securities Litigation Reform Act of 1995 , and it is the Company’s intent that any such statements be protected by the safe h |
|
| May 7, 2025 |
Results of Operations and Financial Condition, Financial Statements and Exhibits UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(D) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of earliest event reported): May 7, 2025 (May 7, 2025) Global Medical REIT Inc. (Exact name of registrant as specified in its charter) Maryland 001-37815 46-4757266 (State or Other Jurisdiction of Incorporation) |
|
| March 31, 2025 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 (Amendment No. ) Filed by the Registrant ☒ Filed by a Party other than the Registrant ☐ Check the appropriate box: ☐ Preliminary Proxy Statement ☐ Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e)(2)) ☒ Defin |
|
| March 31, 2025 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 (Amendment No. ) Filed by the Registrant x Filed by a Party other than the Registrant ¨ Check the appropriate box: ¨ Preliminary Proxy Statement ¨ Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e)(2)) ¨ Defin |
|
| February 28, 2025 |
F UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K Table of Contents F UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D. |
|
| February 28, 2025 |
Exhibit 21 SUBSIDIARIES OF THE REGISTRANT The Company has the following wholly owned subsidiaries as of December 31, 2024: Name State of Organization Global Medical REIT L. |
|
| February 28, 2025 |
Global Medical REIT Inc. Insider Trading Policy. Exhibit 19.1 GLOBAL MEDICAL REIT INC. INSIDER TRADING POLICY Introduction While performing their duties, the persons identified below as “Covered Persons” may learn material, nonpublic information about Global Medical REIT Inc. (the “Company”) or another company. This information may be valuable to those who trade in Company shares or the shares of other companies. It is the law, as well as in the |
|
| February 27, 2025 |
Exhibit 99.2 FOURTH QUARTER 2024 EARNINGS SUPPLEMENTAL www.globalmedicalreit.com NYSE: GMRE Atrium Health – Winston - Salem, NC Forward - Looking Statements Certain statements contained herein may be considered “forward - looking statements” within the meaning of the Private Securities Litigation Reform Act of 1995 , and it is the Company’s intent that any such statements be protected by the safe |
|
| February 27, 2025 |
Results of Operations and Financial Condition, Financial Statements and Exhibits UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(D) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of earliest event reported): February 27, 2025 (February 27, 2025) Global Medical REIT Inc. (Exact name of registrant as specified in its charter) Maryland 001-37815 46-4757266 (State or Other Jurisdiction of Inc |
|
| February 27, 2025 |
Exhibit 99.1 Global Medical REIT Announces Fourth Quarter and Full Year 2024 Financial Results – Acquires $80.3 Million of Single Tenant Triple-Net Medical Real Estate in 2024 – – Announces Joint Venture with Heitman – – Announces First Quarter 2025 Common and Preferred Dividends – – Announces Full Year 2025 AFFO Guidance – Bethesda, MD – February 27, 2025 – (BUSINESS WIRE) – Global Medical REIT I |
|
| January 8, 2025 |
Exhibit 10.1 Execution Version TRANSITION AND SEPARATION AGREEMENT AND GENERAL RELEASE OF CLAIMS This Transition and Separation Agreement and General Release of Claims (this “Agreement”) is entered into as of January 8, 2025 (the “Effective Date”) by and between Jeffrey Busch (“Employee”) and Inter-American Management LLC, a Delaware limited liability company (the “Company”). Global Medical |
|
| January 8, 2025 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(D) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of earliest event reported): January 8, 2025 (January 8, 2025) Global Medical REIT Inc. (Exact name of registrant as specified in its charter) Maryland 001-37815 46-4757266 (State or Other Jurisdiction of Incorpo |
|
| January 8, 2025 |
Exhibit 99.1 Global Medical REIT Announces Succession Plan Chief Executive Officer Transition Expected in 2025 Mr. Busch to Remain on Board of Directors as Non-Executive Chairman Lori Wittman Appointed Lead Independent Director Effective January 1, 2025. Bethesda, MD – January 8, 2025 – (BUSINESS WIRE) – Global Medical REIT Inc. (NYSE: GMRE) (the “Company” or “GMRE”), a net-lease medical real esta |
|
| November 15, 2024 |
Regulation FD Disclosure, Financial Statements and Exhibits UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(D) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of earliest event reported): November 15, 2024 (November 15, 2024) Global Medical REIT Inc. (Exact name of registrant as specified in its charter) Maryland 001-37815 46-4757266 (State or Other Jurisdiction of Inc |
|
| November 15, 2024 |
NIMBLE. TENACIOUS. DISCIPLINED. Investor Presentation November 2024 Exhibit 99.1 NIMBLE. TENACIOUS. DISCIPLINED. Investor Presentation November 2024 Our primary mission is to attain earnings growth and dividend stability by maximizing the investment spread in our healthcare real estate assets. Our strategies to achieve this mission are as follows: • Asset Type - primarily invest in off - campus, out - patient medical facilities, and post - acute, in - patient medi |
|
| November 7, 2024 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 FORM 10-Q Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 FORM 10-Q ☑ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended September 30, 2024 or ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to . |
|
| November 6, 2024 |
THIRD QUARTER 2024 EARNINGS SUPPLEMENTAL www.globalmedicalreit.com NYSE: GMRE Exhibit 99.2 THIRD QUARTER 2024 EARNINGS SUPPLEMENTAL www.globalmedicalreit.com NYSE: GMRE Forward - Looking Statements Certain statements contained herein may be considered “forward - looking statements” within the meaning of the Private Securities Litigation Reform Act of 1995 , and it is the Company’s intent that any such statements be protected by the safe harbor created thereby . These forwar |
|
| November 6, 2024 |
Exhibit 99.1 Global Medical REIT Announces Third Quarter 2024 Financial Results Year-to-Date Completed $80.3 Million in Acquisitions of Single Tenant Triple Net Medical Real Estate Bethesda, MD – November 6, 2024 – (BUSINESS WIRE) – Global Medical REIT Inc. (NYSE: GMRE) (the “Company” or “GMRE”), a net-lease medical real estate investment trust (REIT) that acquires healthcare facilities and leases |
|
| November 6, 2024 |
Financial Statements and Exhibits, Results of Operations and Financial Condition UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(D) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of earliest event reported): November 6, 2024 (November 6, 2024) Global Medical REIT Inc. (Exact name of registrant as specified in its charter) Maryland 001-37815 46-4757266 (State or Other Jurisdiction of Incor |
|
| September 17, 2024 |
Exhibit 99.1 Global Medical REIT Announces Lease with CHRISTUS Health at its Facility in Beaumont, Texas CHRISTUS Health Lease is a triple-net lease with a term of 15 years Former tenant, Steward Health Care, formally requested that its lease be rejected as of September 15, 2024, as part of its Chapter 11 bankruptcy proceedings Bethesda, MD – September 17, 2024 – (BUSINESS WIRE) – Global Medical R |
|
| September 17, 2024 |
Other Events, Financial Statements and Exhibits UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(D) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of earliest event reported): September 17, 2024 Global Medical REIT Inc. (Exact name of registrant as specified in its charter) Maryland 001-37815 46-4757266 (State or Other Jurisdiction of Incorporation) (Commis |
|
| August 12, 2024 |
Calculation of Filing Fee Tables Calculation of Filing Fee Tables S-8 Global Medical REIT Inc. Table 1: Newly Registered Securities Security Type Security Class Title Fee Calculation Rule Amount Registered Proposed Maximum Offering Price Per Unit Maximum Aggregate Offering Price Fee Rate Amount of Registration Fee 1 Equity Common Stock, par value $0.001 per share Other 1,650,000 $ 9.15 $ 15,097,500.00 0.0001476 $ 2,228.39 Total O |
|
| August 12, 2024 |
As filed with the Securities and Exchange Commission on August 12, 2024 As filed with the Securities and Exchange Commission on August 12, 2024 Registration No. |
|
| August 7, 2024 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 FORM 10-Q Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 FORM 10-Q ☑ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended June 30, 2024 or ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to . |
|
| August 6, 2024 |
Exhibit 99.2 SECOND QUARTER 2024 EARNINGS SUPPLEMENTAL www.globalmedicalreit.com NYSE: GMRE Atrium Health – Winston - Salem, NC Forward - Looking Statements Certain statements contained herein may be considered “forward - looking statements” within the meaning of the Private Securities Litigation Reform Act of 1995 , and it is the Company’s intent that any such statements be protected by the safe |
|
| August 6, 2024 |
Financial Statements and Exhibits, Results of Operations and Financial Condition UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(D) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of earliest event reported): August 6, 2024 (August 6, 2024) Global Medical REIT Inc. (Exact name of registrant as specified in its charter) Maryland 001-37815 46-4757266 (State or Other Jurisdiction of Incorpora |
|
| August 6, 2024 |
Exhibit 99.1 Global Medical REIT Announces Second Quarter 2024 Financial Results Completes $31 million in Acquisitions of Single Tenant Triple Net Medical Real Estate in July Bethesda, MD – August 6, 2024 – (BUSINESS WIRE) – Global Medical REIT Inc. (NYSE: GMRE) (the “Company” or “GMRE”), a net-lease medical real estate investment trust (REIT) that acquires healthcare facilities and leases those f |
|
| July 3, 2024 |
July 3, 2024 VIA EDGAR United States Securities and Exchange Commission Division of Corporation Finance Office of Real Estate & Construction 100 F Street, N. |
|
| June 6, 2024 |
Submission of Matters to a Vote of Security Holders UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K/A CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of earliest event reported): June 6, 2024 (May 15, 2024) Global Medical REIT Inc. (Exact name of registrant as specified in its charter) Maryland 001-37815 46-4757266 (State or other jurisdiction of incorporati |
|
| June 3, 2024 |
Regulation FD Disclosure, Financial Statements and Exhibits UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(D) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of earliest event reported): June 3, 2024 (June 3, 2024) Global Medical REIT Inc. (Exact name of registrant as specified in its charter) Maryland 001-37815 46-4757266 (State or Other Jurisdiction of Incorporation |
|
| June 3, 2024 |
NIMBLE. TENACIOUS. DISCIPLINED. Investor Presentation June 2024 Exhibit 99.1 NIMBLE. TENACIOUS. DISCIPLINED. Investor Presentation June 2024 Our primary mission is to attain earnings growth and dividend stability by maximizing the investment spread in our healthcare real estate assets. Our strategies to achieve this mission are as follows: • Asset Type - primarily invest in off - campus, out - patient medical facilities, and post - acute, in - patient medical |
|
| May 16, 2024 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of earliest event reported): May 16, 2024 (May 15, 2024) Global Medical REIT Inc. (Exact name of registrant as specified in its charter) Maryland 001-37815 46-4757266 (State or other jurisdiction of incorporation |
|
| May 8, 2024 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 FORM 10-Q Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 FORM 10-Q ☑ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended March 31, 2024 or ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to . |
|
| May 7, 2024 |
Financial Statements and Exhibits, Results of Operations and Financial Condition UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(D) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of earliest event reported): May 7, 2024 (May 7, 2024) Global Medical REIT Inc. (Exact name of registrant as specified in its charter) Maryland 001-37815 46-4757266 (State or Other Jurisdiction of Incorporation) |
|
| May 7, 2024 |
Exhibit 99.2 FIRST QUARTER 2024 EARNINGS SUPPLEMENTAL www.globalmedicalreit.com NYSE: GMRE Atrium Health – Winston - Salem, NC Forward - Looking Statements Certain statements contained herein may be considered “forward - looking statements” within the meaning of the Private Securities Litigation Reform Act of 1995 , and it is the Company’s intent that any such statements be protected by the safe h |
|
| May 7, 2024 |
Global Medical REIT Announces First Quarter 2024 Financial Results Exhibit 99.1 Global Medical REIT Announces First Quarter 2024 Financial Results Bethesda, MD – May 7, 2024 – (BUSINESS WIRE) – Global Medical REIT Inc. (NYSE: GMRE) (the “Company” or “GMRE”), a net-lease medical real estate investment trust (REIT) that acquires healthcare facilities and leases those facilities to physician groups and regional and national healthcare systems, today announced financ |
|
| April 5, 2024 |
Up to $300,000,000 Common Stock Filed Pursuant to Rule 424(b)(5) Registration No. 333-276248 PROSPECTUS SUPPLEMENT (To prospectus dated April 4, 2024) Up to $300,000,000 Common Stock We and Global Medical REIT L.P. previously entered into a sales agreement, dated January 9, 2024 (the “Sales Agreement”), with BMO Capital Markets Corp., B. Riley Securities, Inc., Robert W. Baird & Co. Incorporated, Berenberg Capital Markets LLC, C |
|
| April 5, 2024 |
Financial Statements and Exhibits, Other Events UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(D) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of earliest event reported): April 5, 2024 Global Medical REIT Inc. (Exact name of registrant as specified in its charter) Maryland 001-37815 46-4757266 (State or Other Jurisdiction of Incorporation) (Commission |
|
| April 1, 2024 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 (Amendment No. ) Filed by the Registrant ☒ Filed by a Party other than the Registrant ☐ Check the appropriate box: ☐ Preliminary Proxy Statement ☐ Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e)(2)) ☒ Defin |
|
| April 1, 2024 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 (Amendment No. ) Filed by the Registrant x Filed by a Party other than the Registrant ¨ Check the appropriate box: ¨ Preliminary Proxy Statement ¨ Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e)(2)) ¨ Defin |
|
| March 5, 2024 |
Financial Statements and Exhibits, Other Events UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(D) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of earliest event reported): February 27, 2024 Global Medical REIT Inc. (Exact name of registrant as specified in its charter) Maryland 001-37815 46-4757266 (State or Other Jurisdiction of Incorporation) (Commiss |
|
| February 29, 2024 |
As filed with the Securities and Exchange Commission on February 29, 2024 As filed with the Securities and Exchange Commission on February 29, 2024 Registration No. |
|
| February 28, 2024 |
Exhibit 21 SUBSIDIARIES OF THE REGISTRANT The Company has the following wholly owned subsidiaries as of December 31, 2023: Name State of Organization Global Medical REIT L. |
|
| February 28, 2024 |
Policy Relating to Recovery of Erroneously Awarded Compensation. Exhibit 97.1 Global Medical REIT Inc. Clawback Policy (this “Policy”) Adopted by the Board of Directors (the “Board”) of Global Medical REIT Inc. (the “Company”) on October 18, 2023. This Policy supersedes and replaces all prior and contemporaneous policies of the Company, oral or written, regarding the subject matter contained herein. 1. Recoupment. If the Company is required to prepare a Restate |
|
| February 28, 2024 |
F UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K Table of Contents F UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D. |
|
| February 27, 2024 |
Up to $300,000,000 Common Stock Filed Pursuant to Rule 424(b)(5) Registration No. 333-276248 PROSPECTUS SUPPLEMENT (To prospectus dated February 27, 2024) Up to $300,000,000 Common Stock We and Global Medical REIT L.P. previously entered into a sales agreement, dated January 9, 2024 (the “Sales Agreement”), with BMO Capital Markets Corp., B. Riley Securities, Inc., Robert W. Baird & Co. Incorporated, Berenberg Capital Markets LL |
|
| February 27, 2024 |
Exhibit 99.1 Global Medical REIT Announces Fourth Quarter and Year-End 2023 Financial Results Net Proceeds From 2023 Dispositions Used to Reduce Leverage and Position Company for Growth Bethesda, MD – February 27, 2024 – (BUSINESS WIRE) – Global Medical REIT Inc. (NYSE: GMRE) (the “Company” or “GMRE”), a net-lease medical office real estate investment trust (REIT) that acquires healthcare faciliti |
|
| February 27, 2024 |
As filed with the Securities and Exchange Commission on February 27, 2024 As filed with the Securities and Exchange Commission on February 27, 2024 Registration No. |
|
| February 27, 2024 |
Exhibit 99.2 FOURTH QUARTER 2023 EARNINGS SUPPLEMENTAL www.globalmedicalreit.com NYSE: GMRE Atrium Health – Winston - Salem, NC Forward - Looking Statements Certain statements contained herein may be considered “forward - looking statements” within the meaning of the Private Securities Litigation Reform Act of 1995 , and it is the Company’s intent that any such statements be protected by the safe |
|
| February 27, 2024 |
Financial Statements and Exhibits, Results of Operations and Financial Condition UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(D) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of earliest event reported): February 27, 2024 (February 27, 2024) Global Medical REIT Inc. (Exact name of registrant as specified in its charter) Maryland 001-37815 46-4757266 (State or Other Jurisdiction of Inc |
|
| February 27, 2024 |
Exhibit 107 Calculation of Filing Fee Tables FORM S-3 (Form Type) Global Medical REIT Inc. |
|
| February 13, 2024 |
GMRE / Global Medical REIT Inc. / VANGUARD GROUP INC - SCHEDULE 13G/A Passive Investment SC 13G/A 1 tv01024-globalmedicalreitinc.htm SCHEDULE 13G/A SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Schedule 13G Under the Securities Exchange Act of 1934 (Amendment No.: 5)* Name of issuer: Global Medical REIT Inc Title of Class of Securities: Common Stock CUSIP Number: 37954A204 Date of Event Which Requires Filing of this Statement: December 29, 2023 Check the appropriate box to |
|
| January 9, 2024 |
Exhibit 1.1 GLOBAL MEDICAL REIT INC. UP TO $300,000,000 SHARES OF COMMON STOCK SALES AGREEMENT January 9, 2024 As Agents: BMO CAPITAL MARKETS CORP. 151 W 42nd St New York, NY 10036 CITIZENS JMP SECURITIES, LLC 450 Park Avenue, 5th Floor New York, NY 10022 B. RILEY SECURITIES, INC. 299 Park Avenue, 21st Floor New York, NY 10171 J.P. MORGAN sECURITIES LLC 383 Madison Avenue, 6th Floor New York, NY 1 |
|
| January 9, 2024 |
Exhibit 107.1 Calculation of Filing Fee Tables Form S-3 (Form Type) Global Medical REIT Inc. (Exact Name of Registrant as Specified in its Charter) Table 1: Newly Registered Securities Security Type Security Class Title Fee Calculation or Carry Forward Rule Amount Registered Proposed Maximum Offering Price Per Unit Maximum Aggregate Offering Price Fee Rate Amount of Registration Fee Equity Common |
|
| January 9, 2024 |
FORM OF MASTER FORWARD CONFIRMATION Exhibit 99.1 FORM OF MASTER FORWARD CONFIRMATION To: Global Medical REIT Inc. (“Counterparty”) From: [ ] (“Dealer”) [ ] Re: Master Confirmation for Issuer Share Forward Sale Transactions Date: January [9], 2024 Ladies and Gentlemen: The purpose of this communication (this “Master Confirmation”) is to set forth the terms and conditions of the transactions to be entered int |
|
| January 9, 2024 |
Up to $300,000,000 Common Stock Filed Pursuant to Rule 424(b)(5) Registration No. 333-276248 PROSPECTUS SUPPLEMENT (To prospectus dated December 22, 2023) Up to $300,000,000 Common Stock We and Global Medical REIT L.P. have entered into a sales agreement (the “Sales Agreement”) with BMO Capital Markets Corp., B. Riley Securities, Inc., Robert W. Baird & Co. Incorporated, Berenberg Capital Markets LLC, Colliers Securities LLC, |
|
| January 9, 2024 |
Entry into a Material Definitive Agreement, Financial Statements and Exhibits UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of earliest event reported): January 9, 2024 (January 9, 2024) Global Medical REIT Inc. (Exact name of registrant as specified in its charter) Maryland 001-37815 46-4757266 (State or other jurisdiction of incorpo |
|
| December 22, 2023 |
Exhibit 4.5 GLOBAL MEDICAL REIT INC. TO , Trustee Indenture (For [Subordinated]* Debt Securities) Dated as of , 20 TABLE OF CONTENTS† Page RECITAL OF THE COMPANY 1 Article I DEFINITIONS AND OTHER PROVISIONS OF GENERAL APPLICATION 1 Section 1.01. Definitions 1 Section 1.02. Compliance Certificates and Opinions 8 Section 1.03. Form of Documents Delivered to Trustee 9 Section 1.04. Acts of Holders 10 |
|
| December 22, 2023 |
As filed with the Securities and Exchange Commission on December 22, 2023 As filed with the Securities and Exchange Commission on December 22, 2023 Registration No. |
|
| December 22, 2023 |
Exhibit 107 Calculation of Filing Fee Tables FORM S-3 (Form Type) Global Medical REIT Inc. |
|
| November 13, 2023 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(D) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of earliest event reported): November 13, 2023 (November 13, 2023) Global Medical REIT Inc. (Exact name of registrant as specified in its charter) Maryland 001-37815 46-4757266 (State or Other Jurisdiction of Inc |
|
| November 13, 2023 |
NIMBLE. TENACIOUS. DISCIPLINED. Investor Presentation November 2023 Exhibit 99.1 NIMBLE. TENACIOUS. DISCIPLINED. Investor Presentation November 2023 Our primary mission is to attain earnings growth and dividend stability by maximizing the investment spread in our healthcare real estate assets. Our strategies to achieve this mission are as follows: • Asset Type - primarily invest in off - campus medical office and post - acute, in - patient medical facilities; • As |
|
| November 7, 2023 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 FORM 10-Q Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 FORM 10-Q ☑ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended September 30, 2023 or ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to . |
|
| November 6, 2023 |
Financial Statements and Exhibits, Results of Operations and Financial Condition UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(D) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of earliest event reported): November 6, 2023 (November 6, 2023) Global Medical REIT Inc. (Exact name of registrant as specified in its charter) Maryland 001-37815 46-4757266 (State or Other Jurisdiction of Incor |
|
| November 6, 2023 |
Exhibit 99.2 THIRD QUARTER 2023 EARNINGS SUPPLEMENTAL www.globalmedicalreit.com NYSE: GMRE Atrium Health – Winston - Salem, NC Forward - Looking Statements Certain statements contained herein may be considered “forward - looking statements” within the meaning of the Private Securities Litigation Reform Act of 1995 , and it is the Company’s intent that any such statements be protected by the safe h |
|
| November 6, 2023 |
Exhibit 99.1 Global Medical REIT Announces Third Quarter 2023 Financial Results Year-to-Date Completed Three Dispositions Generating Aggregate Gross Proceeds of $80.5 million Resulting in an Aggregate Gain of $15.6 Million Bethesda, MD – November 6, 2023 – (BUSINESS WIRE) – Global Medical REIT Inc. (NYSE: GMRE) (the “Company” or “GMRE”), a net-lease medical office real estate investment trust (REI |
|
| August 4, 2023 |
Form of LTIP Agreement (Annual Awards). Exhibit 10.1 GLOBAL MEDICAL REIT INC. 2016 ANNUAL INCENTIVE PLAN LTIP UNIT VESTING AGREEMENT Annual Award (Performance-Based with Time-Vesting) Name of Grantee: Number of Award LTIP Units: Grant Date: Final Acceptance Date: Pursuant to the Global Medical REIT Inc. 2016 Equity Incentive Plan, as amended from time to time (the “Plan”), and the Agreement of Limited Partnership, dated as of March 14, |
|
| August 4, 2023 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 FORM 10-Q Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 FORM 10-Q ☑ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended June 30, 2023 or ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to . |
|
| August 2, 2023 |
Exhibit 99.2 SECOND QUARTER 2023 EARNINGS SUPPLEMENTAL www.globalmedicalreit.com NYSE: GMRE Atrium Health – Winston - Salem, NC Forward - Looking Statements Certain statements contained herein may be considered “forward - looking statements” within the meaning of the Private Securities Litigation Reform Act of 1995 , and it is the Company’s intent that any such statements be protected by the safe |
|
| August 2, 2023 |
Exhibit 99.1 Global Medical REIT Announces Second Quarter 2023 Financial Results Completes Disposition of a Four Property MOB Portfolio Receiving Gross Proceeds of $66 million Resulting in a Gain of $12.8 Million Bethesda, MD – August 2, 2023 – (BUSINESS WIRE) – Global Medical REIT Inc. (NYSE: GMRE) (the “Company” or “GMRE”), a net-lease medical office real estate investment trust (REIT) that acqu |
|
| August 2, 2023 |
Financial Statements and Exhibits, Results of Operations and Financial Condition UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(D) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of earliest event reported): August 2, 2023 (August 2, 2023) Global Medical REIT Inc. (Exact name of registrant as specified in its charter) Maryland 001-37815 46-4757266 (State or Other Jurisdiction of Incorpora |
|
| June 6, 2023 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(D) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of earliest event reported): June 6, 2023 (June 6, 2023) Global Medical REIT Inc. (Exact name of registrant as specified in its charter) Maryland 001-37815 46-4757266 (State or Other Jurisdiction of Incorporation |
|
| June 6, 2023 |
Exhibit 99.1 NIMBLE. TENACIOUS. DISCIPLINED. Investor Presentation June 2023 Our primary mission is to attain earnings growth and dividend stability by maximizing the investment spread in our healthcare real estate assets. Our strategies to achieve this mission are as follows: • Asset Type - primarily invest in off - campus medical office and post - acute, in - patient medical facilities; • Asset |
|
| May 15, 2023 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(D) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of earliest event reported): May 15, 2023 (May 15, 2023) Global Medical REIT Inc. (Exact name of registrant as specified in its charter) Maryland 001-37815 46-4757266 (State or Other Jurisdiction of Incorporation |
|
| May 15, 2023 |
NIMBLE. TENACIOUS. DISCIPLINED. Investor Presentation May 2023 Exhibit 99.1 NIMBLE. TENACIOUS. DISCIPLINED. Investor Presentation May 2023 Our goal is to deliver attractive, risk - adjusted returns by investing in quality healthcare assets. As a primarily net - leased medical office real estate investment trust (REIT), we target properties operated by profitable healthcare systems or physician groups that are at the forefront of delivering needed care in thei |
|
| May 10, 2023 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of earliest event reported): May 10, 2023 (May 10, 2023) Global Medical REIT Inc. (Exact name of registrant as specified in its charter) Maryland 001-37815 46-4757266 (State or other jurisdiction of incorporation |
|
| May 5, 2023 |
Form of LTIP Agreement (Long-Term Time-Based Awards). Exhibit 10.2 GLOBAL MEDICAL REIT INC. 2016 EQUITY INCENTIVE PLAN LTIP UNIT AWARD AGREEMENT Long-Term Incentive Award (Time-Vesting) Name of Grantee: Number of LTIP Units: Grant Date (Closing Date): Final Acceptance Date: Pursuant to the Global Medical REIT Inc. 2016 Equity Incentive Plan, as amended from time to time (the “Plan”), and the Agreement of Limited Partnership, dated as of March 14, 201 |
|
| May 5, 2023 |
Form of LTIP Agreement (Long-Term Performance Awards). Exhibit 10.1 GLOBAL MEDICAL REIT INC. 2016 EQUITY INCENTIVE PLAN LTIP UNIT AWARD AGREEMENT Long Term Incentive Award (Performance-Based with Time-Vesting) Name of Grantee: Number of LTIP Units: Grant Date (Closing Date): Final Acceptance Date: , Pursuant to the Global Medical REIT Inc. 2016 Equity Incentive Plan, as amended from time to time (the “Plan”), and the Agreement of Limited Partnership, |
|
| May 5, 2023 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 FORM 10-Q Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 FORM 10-Q ☑ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended March 31, 2023 or ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to . |
|
| May 3, 2023 |
Financial Statements and Exhibits, Results of Operations and Financial Condition UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(D) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of earliest event reported): May 3, 2023 (May 3, 2023) Global Medical REIT Inc. (Exact name of registrant as specified in its charter) Maryland 001-37815 46-4757266 (State or Other Jurisdiction of Incorporation) |
|
| May 3, 2023 |
Exhibit 99.2 First Quarter 2023 Earnings Supplemental www.globalmedicalreit.com NYSE: GMRE Wake Forest Medical – Winston - Salem, NC Atrium Health – Winston - Salem, NC Table of Contents Table of Contents Company Overview 3 - 5 Select Quarterly Financial Data 6 Business Summary 7 ESG Summary 8 Portfolio Summary 9 - 10 Top 10 Tenants 11 - 13 Debt and Hedging Summary 14 Total Capitalization and Equi |
|
| May 3, 2023 |
Global Medical REIT Announces First Quarter 2023 Financial Results Exhibit 99.1 Global Medical REIT Announces First Quarter 2023 Financial Results Bethesda, MD – May 3, 2023 – (BUSINESS WIRE) – Global Medical REIT Inc. (NYSE: GMRE) (the “Company” or “GMRE”), a net-lease medical office real estate investment trust (REIT) that owns and acquires healthcare facilities and leases those facilities to physician groups and regional and national healthcare systems, today |
|
| March 31, 2023 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 (Amendment No. ) Filed by the Registrant x Filed by a Party other than the Registrant ¨ Check the appropriate box: ¨ Preliminary Proxy Statement ¨ Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e)(2)) ¨ Defin |
|
| March 31, 2023 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 (Amendment No. ) Filed by the Registrant ☒ Filed by a Party other than the Registrant ☐ Check the appropriate box: ☐ Preliminary Proxy Statement ☐ Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e)(2)) ☒ Defin |
|
| March 1, 2023 |
Exhibit 21 SUBSIDIARIES OF THE REGISTRANT The Company has the following wholly owned subsidiaries as of December 31, 2022: Name State of Organization Global Medical REIT L. |
|
| March 1, 2023 |
F UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K Table of Contents F UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D. |
|
| February 28, 2023 |
Exhibit 99.1 Global Medical REIT Announces Fourth Quarter and Year-End 2022 Financial Results Acquires $149 Million in Medical Real Estate During 2022 Bethesda, MD – February 28, 2023 – (BUSINESS WIRE) – Global Medical REIT Inc. (NYSE: GMRE) (the “Company” or “GMRE”), a net-lease medical office real estate investment trust (REIT) that owns and acquires healthcare facilities and leases those facili |
|
| February 28, 2023 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(D) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of earliest event reported): February 28, 2023 (February 28, 2023) Global Medical REIT Inc. (Exact name of registrant as specified in its charter) Maryland 001-37815 46-4757266 (State or Other Jurisdiction of Inc |
|
| February 28, 2023 |
Exhibit 99.2 Fourth Quarter 2022 Earnings Supplemental www.globalmedicalreit.com NYSE: GMRE Wake Forest Medical – Winston - Salem, NC Atrium Health – Winston - Salem, NC Table of Contents Table of Contents Company Overview 3 - 5 Select Quarterly Financial Data 6 Business Summary 7 ESG Summary 8 Acquisitions 9 Portfolio Summary 10 - 11 Top 10 Tenants 12 - 14 Debt and Hedging Summary 15 Total Capita |
|
| February 9, 2023 |
GMRE / Global Medical REIT Inc / VANGUARD GROUP INC - SCHEDULE 13G/A Passive Investment SC 13G/A 1 tv0989-globalmedicalreitinc.htm SCHEDULE 13G/A SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Schedule 13G Under the Securities Exchange Act of 1934 (Amendment No.: 4)* Name of issuer: Global Medical REIT Inc. Title of Class of Securities: REIT CUSIP Number: 37954A204 Date of Event Which Requires Filing of this Statement: December 30, 2022 Check the appropriate box to designa |
|
| January 23, 2023 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(D) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of earliest event reported): January 23, 2023 (January 19, 2023) Global Medical REIT Inc. (Exact name of registrant as specified in its charter) Maryland 001-37815 46-4757266 (State or Other Jurisdiction of Incor |
|
| December 7, 2022 |
Exhibit 3.2 GLOBAL MEDICAL REIT INC. FOURTH AMENDED AND RESTATED BYLAWS Adopted as of December 7, 2022 Article I OFFICES Section 1. PRINCIPAL OFFICE. The principal office of Global Medical REIT Inc., a Maryland corporation (the ?Corporation?), in the State of Maryland shall be located at such place as the board of directors of the Corporation (the ?Board of Directors? or ?board?) may designate. Se |
|
| December 7, 2022 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(D) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of earliest event reported): December 7, 2022 (December 7, 2022) Global Medical REIT Inc. (Exact name of registrant as specified in its charter) Maryland 001-37815 46-4757266 (State or Other Jurisdiction of Incor |
|
| November 14, 2022 |
Regulation FD Disclosure, Financial Statements and Exhibits UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(D) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of earliest event reported): November 14, 2022 (November 14, 2022) Global Medical REIT Inc. (Exact name of registrant as specified in its charter) Maryland 001-37815 46-4757266 (State or Other Jurisdiction of Inc |
|
| November 14, 2022 |
NIMBLE. TENACIOUS. DISCIPLINED. Investor Presentation November 2022 Exhibit 99.1 NIMBLE. TENACIOUS. DISCIPLINED. Investor Presentation November 2022 Our goal is to deliver attractive, risk - adjusted returns by investing in quality healthcare assets. As a primarily net - leased medical office real estate investment trust (REIT), we target properties operated by profitable healthcare systems or physician groups that are at the forefront of delivering needed care in |
|
| November 4, 2022 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 FORM 10-Q Table of Contents ? ? UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 FORM 10-Q ? ? ? QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 ? For the quarterly period ended September 30, 2022 or ? ? ? ? TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 ? For the transition period from to . |
|
| November 2, 2022 |
Financial Statements and Exhibits, Results of Operations and Financial Condition UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(D) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of earliest event reported): November 2, 2022 (November 2, 2022) Global Medical REIT Inc. (Exact name of registrant as specified in its charter) Maryland 001-37815 46-4757266 (State or Other Jurisdiction of Incor |
|
| November 2, 2022 |
Exhibit 99.2 Third Quarter 2022 Earnings Supplemental www.globalmedicalreit.com NYSE: GMRE Wake Forest Medical ? Winston - Salem, NC Atrium Health ? Winston - Salem, NC Table of Contents Table of Contents Company Overview 3 - 5 Select Quarterly Financial Data 6 Business Summary 7 ESG Summary 8 Acquisitions 9 Portfolio Summary 10 - 11 Top 10 Tenants 12 - 14 Debt and Hedging Summary 15 Total Capital |
|
| November 2, 2022 |
Exhibit 99.1 Global Medical REIT Announces Third Quarter 2022 Financial Results Invests $51 Million in Medical Real Estate During Third Quarter and $149 Million Year-to-Date Adds $150 Million Term Loan to Credit Facility 80% of Overall Indebtedness is Fixed-Rate Debt Bethesda, MD ? November 2, 2022 ? (BUSINESS WIRE) ? Global Medical REIT Inc. (NYSE: GMRE) (the ?Company? or ?GMRE?), a net-lease med |
|
| October 6, 2022 |
Regulation FD Disclosure, Financial Statements and Exhibits UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(D) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of earliest event reported): October 6, 2022 (October 3, 2022) Global Medical REIT Inc. (Exact name of registrant as specified in its charter) Maryland 001-37815 46-4757266 (State or Other Jurisdiction of Incorpo |
|
| August 5, 2022 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 FORM 10-Q Table of Contents ? ? UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 FORM 10-Q ? ? ? QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 ? For the quarterly period ended June 30, 2022 or ? ? ? ? TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 ? For the transition period from to . |
|
| August 3, 2022 |
Exhibit 99.1 Global Medical REIT Announces Second Quarter 2022 Financial Results Invests $74 Million in Medical Real Estate During Second Quarter and $121 Million Year-to-Date, with an additional $50 Million Under Contract Adds $150 Million Delayed-Draw Term Loan to Credit Facility Bethesda, MD ? August 3, 2022 ? (BUSINESS WIRE) ? Global Medical REIT Inc. (NYSE: GMRE) (the ?Company? or ?GMRE?), a |
|
| August 3, 2022 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(D) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of earliest event reported): August 3, 2022 (August 1, 2022) Global Medical REIT Inc. (Exact name of registrant as specified in its charter) Maryland 001-37815 46-4757266 (State or Other Jurisdiction of Incorpora |
|
| August 3, 2022 |
Exhibit 10.1 AMENDMENT NO. 1 TO SECOND AMENDED AND RESTATED CREDIT AGREEMENT This AMENDMENT NO. 1 TO SECOND AMENDED AND RESTATED CREDIT AGREEMENT, dated as of August 1, 2022 (this ?Amendment No. 1?), is by and among Global Medical REIT L.P., a Delaware limited partnership (the ?Borrower?), Global Medical REIT Inc., a Maryland corporation (the ?Parent? or ?Global Medical REIT?), the certain Subsidi |
|
| August 3, 2022 |
Exhibit 99.2 Second Quarter 2022 Earnings Supplemental Three and Six Months Ended June 30, 2022 www.globalmedicalreit.com NYSE: GMRE Corporate Information and Analyst Coverage 2 2Q - 2022| Earnings Supplemental Executive Team Jeffrey Busch Chief Executive Officer, Chairman and President Alfonzo Leon Chief Investment Officer Danica Holley Chief Operating Officer Bob Kiernan Chief Financial Officer |
|
| June 28, 2022 |
NIMBLE. TENACIOUS. DISCIPLINED. Investor Presentation June 2022 Exhibit 99.1 NIMBLE. TENACIOUS. DISCIPLINED. Investor Presentation June 2022 Our goal is to deliver attractive, risk - adjusted returns by investing in quality healthcare assets. As a primarily net - leased medical office real estate investment trust (REIT), we target properties operated by profitable healthcare systems or physician groups that are at the forefront of delivering needed care in the |
|
| June 28, 2022 |
Regulation FD Disclosure, Financial Statements and Exhibits UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(D) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of earliest event reported): June 28, 2022 (June 28, 2022) Global Medical REIT Inc. (Exact name of registrant as specified in its charter) Maryland 001-37815 46-4757266 (State or Other Jurisdiction of Incorporati |
|
| June 6, 2022 |
Regulation FD Disclosure, Financial Statements and Exhibits UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(D) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of earliest event reported): June 6, 2022 (June 6, 2022) Global Medical REIT Inc. (Exact name of registrant as specified in its charter) Maryland 001-37815 46-4757266 (State or Other Jurisdiction of Incorporation |
|
| June 6, 2022 |
NIMBLE. TENACIOUS. DISCIPLINED. Investor Presentation June 2022 Exhibit 99.1 NIMBLE. TENACIOUS. DISCIPLINED. Investor Presentation June 2022 Our goal is to deliver attractive, risk - adjusted returns by investing in quality healthcare assets. As a primarily net - leased medical office real estate investment trust (REIT), we target properties operated by profitable healthcare systems or physician groups that are at the forefront of delivering needed care in the |
|
| May 13, 2022 |
NIMBLE. TENACIOUS. DISCIPLINED. Investor Presentation May 2022 Exhibit 99.1 NIMBLE. TENACIOUS. DISCIPLINED. Investor Presentation May 2022 Our goal is to deliver attractive, risk - adjusted returns by investing in quality healthcare assets. As a primarily net - leased medical office real estate investment trust (REIT), we target properties operated by profitable healthcare systems or physician groups that are at the forefront of delivering needed care in thei |
|
| May 13, 2022 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of earliest event reported): May 13, 2022 (May 11, 2022) Global Medical REIT Inc. (Exact name of registrant as specified in its charter) Maryland 001-37815 46-4757266 (State or other jurisdiction of incorporation |
|
| May 6, 2022 |
Form of LTIP Award Agreement (Long-Term Time-Based Awards). Exhibit 10.3 ? GLOBAL MEDICAL REIT INC. 2016 EQUITY INCENTIVE PLAN ? LTIP UNIT AWARD AGREEMENT Long-Term Incentive Award (Time-Vesting) ? ? Name of Grantee: ? Number of LTIP Units: ? Grant Date (Closing Date): February 24, 2022 Final Acceptance Date: , ? ? Pursuant to the Global Medical REIT Inc. 2016 Equity Incentive Plan, as amended from time to time (the ?Plan?), and the Agreement of Limited Pa |
|
| May 6, 2022 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 FORM 10-Q Table of Contents ? ? UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 FORM 10-Q ? ? ? QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 ? For the quarterly period ended March 31, 2022 or ? ? ? ? TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 ? For the transition period from to . |
|
| May 6, 2022 |
Form of LTIP Award Agreement (Long-Term Performance Awards). Exhibit 10.2 ? GLOBAL MEDICAL REIT INC. 2016 EQUITY INCENTIVE PLAN ? LTIP UNIT AWARD AGREEMENT Long Term Incentive Award (Performance-Based with Time-Vesting) ? ? ? ? Name of Grantee: ? ? Number of LTIP Units: ? ? Grant Date (Closing Date): February 24, 2022 Final Acceptance Date: , ? ? Pursuant to the Global Medical REIT Inc. 2016 Equity Incentive Plan, as amended from time to time (the ?Plan?), |
|
| May 6, 2022 |
Form of LTIP Award Agreement (Annual Awards). ? Exhibit 10.1 GLOBAL MEDICAL REIT INC. 2016 ANNUAL INCENTIVE PLAN LTIP UNIT VESTING AGREEMENT ? Annual Award (Performance-Based with Time-Vesting) ? Name of Grantee: [ ] Number of Award LTIP Units: [ ] Grant Date: February 24, 2022 Final Acceptance Date: [ ], 2022 ? Pursuant to the Global Medical REIT Inc. 2016 Equity Incentive Plan, as amended from time to time (the ?Plan?), and the Agreement of |
|
| May 4, 2022 |
Exhibit 99.1 Global Medical REIT Announces First Quarter 2022 Financial Results Invests $24 Million in Medical Real Estate During First Quarter and $54 Million Year-to-Date, with an additional $53 Million Under Contract Bethesda, MD ? May 4, 2022 ? (BUSINESS WIRE) ? Global Medical REIT Inc. (NYSE: GMRE) (the ?Company? or ?GMRE?), a net-lease medical office real estate investment trust (REIT) that |
|
| May 4, 2022 |
Financial Statements and Exhibits, Results of Operations and Financial Condition UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(D) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of earliest event reported): May 4, 2022 (May 4, 2022) Global Medical REIT Inc. (Exact name of registrant as specified in its charter) Maryland 001-37815 46-4757266 (State or Other Jurisdiction of Incorporation) |
|
| May 4, 2022 |
Exhibit 99.2 First Quarter 2022 Earnings Supplemental Three Months Ended March 31, 2022 www.globalmedicalreit.com NYSE: GMRE Corporate Information and Analyst Coverage 2 1Q - 2022| Earnings Supplemental Executive Team Jeffrey Busch Chief Executive Officer, Chairman and President Alfonzo Leon Chief Investment Officer Danica Holley Chief Operating Officer Bob Kiernan Chief Financial Officer and Trea |
|
| March 31, 2022 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 (Amendment No. ) Filed by the Registrant x Filed by a Party other than the Registrant ? Check the appropriate box: ? Preliminary Proxy Statement ? Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e)(2)) ? Defin |
|
| March 31, 2022 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 (Amendment No. ) Filed by the Registrant x Filed by a Party other than the Registrant ? Check the appropriate box: ? Preliminary Proxy Statement ? Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e)(2)) x Defin |
|
| March 29, 2022 |
Entry into a Material Definitive Agreement, Financial Statements and Exhibits UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of earliest event reported): March 29, 2022 (March 28, 2022) Global Medical REIT Inc. (Exact name of registrant as specified in its charter) Maryland 001-37815 46-4757266 (State or other jurisdiction of incorpora |
|
| March 29, 2022 |
FORM OF MASTER FORWARD CONFIRMATION Exhibit 99.1 FORM OF MASTER FORWARD CONFIRMATION To: Global Medical REIT Inc. (?Counterparty?) From: [ ] (?Dealer?) [ ] Re: Master Confirmation for Issuer Share Forward Sale Transactions Date: March [28], 2022 Ladies and Gentlemen: The purpose of this communication (this ?Master Confirmation?) is to set forth the terms and conditions of the transactions to be entered into from time to time (each, |
|
| March 29, 2022 |
Exhibit 1.1 GLOBAL MEDICAL REIT INC. UP TO $300,000,000 SHARES OF COMMON STOCK SALES AGREEMENT March 28, 2022 As Agents: BMO CAPITAL MARKETS CORP. 151 W 42nd St New York, NY 10036 JMP SECURITIES LLC 450 Park Avenue, 5th Floor New York, NY 10022 B. RILEY SECURITIES, INC. 299 Park Avenue, 21st Floor New York, NY 10171 J.P. MORGAN sECURITIES LLC 383 Madison Avenue New York, NY 10179 ROBERT W. BAIRD & |
|
| March 28, 2022 |
Up to $300,000,000 Common Stock TABLE OF CONTENTS ?Filed Pursuant to Rule 424(b)(5) ?Registration No. 333-239043? PROSPECTUS SUPPLEMENT ?(To prospectus dated June 17, 2020) Up to $300,000,000 Common Stock We and Global Medical REIT L.P. have entered into a sales agreement (the ?Sales Agreement?) with BMO Capital Markets Corp., B. Riley Securities, Inc., Robert W. Baird & Co. Incorporated , Berenberg Capital Markets LLC, Colliers |
|
| March 2, 2022 |
As filed with the Securities and Exchange Commission on March 2, 2022 As filed with the Securities and Exchange Commission on March 2, 2022 Registration No. |
|
| March 2, 2022 |
Exhibit 107 Calculation of Filing Fee Tables Form S-8 (Form Type) Global Medical REIT Inc. |
|
| March 1, 2022 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K Table of Contents ? ? UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D. |
|
| March 1, 2022 |
Exhibit 21 SUBSIDIARIES OF THE REGISTRANT The Company has the following wholly owned subsidiaries as of December 31, 2021: ? Name State of Organization Global Medical REIT L. |
|
| February 28, 2022 |
Exhibit 99.1 Global Medical REIT Announces Fourth Quarter 2021 Financial Results Invests $196 Million in Medical Real Estate During 2021 (including $189 million of new acquisitions and a revenue-generating $7 million expansion of a current facility) Bethesda, MD ? February 28, 2022 - (BUSINESS WIRE) - Global Medical REIT Inc. (NYSE: GMRE) (the ?Company? or ?GMRE?), a net-lease medical office real |
|
| February 28, 2022 |
Financial Statements and Exhibits, Results of Operations and Financial Condition UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(D) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of earliest event reported): February 28, 2022 (February 28, 2022) Global Medical REIT Inc. (Exact name of registrant as specified in its charter) Maryland 001-37815 46-4757266 (State or Other Jurisdiction of Inc |
|
| February 28, 2022 |
Exhibit 99.2 Fourth Quarter 2021 Earnings Supplemental Three and Twelve Months Ended December 31, 2021 www.globalmedicalreit.com NYSE: GMRE Corporate Information and Analyst Coverage 2 4Q - 2021| Earnings Supplemental Executive Team Jeffrey Busch Chief Executive Officer, Chairman and President Alfonzo Leon Chief Investment Officer Danica Holley Chief Operating Officer Bob Kiernan Chief Financial O |
|
| February 10, 2022 |
GMRE / Global Medical REIT Inc / VANGUARD GROUP INC - SCHEDULE 13G/A Passive Investment SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Schedule 13G Under the Securities Exchange Act of 1934 (Amendment No.: 3)* Name of issuer: Global Medical REIT Inc. Title of Class of Securities: REIT CUSIP Number: 37954A204 Date of Event Which Requires Filing of this Statement: December 31, 2021 Check the appropriate box to designate the rule pursuant to which this Schedule is filed: ☒ Ru |
|
| November 9, 2021 |
NIMBLE. TENACIOUS. DISCI P LINED. Investor Presentation November 2021 EX-99.1 2 tm2132385d1ex99-1.htm EXHIBIT 99.1 Exhibit 99.1 NIMBLE. TENACIOUS. DISCI P LINED. Investor Presentation November 2021 Our goal is to deliver attractive, risk - adjusted returns by investing in quality healthcare assets. As a net - lease medical office real estate investment trust (REIT), we target properties operated by profitable healthcare systems or physician groups that are at the fo |
|
| November 9, 2021 |
Regulation FD Disclosure, Financial Statements and Exhibits UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(D) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of earliest event reported): November 9, 2021 (November 9, 2021) Global Medical REIT Inc. (Exact name of registrant as specified in its charter) Maryland 001-37815 46-4757266 (State or Other Jurisdiction of Incor |
|
| November 5, 2021 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 FORM 10-Q Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 FORM 10-Q ☑ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended September 30, 2021 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to . |
|
| November 3, 2021 |
Financial Statements and Exhibits, Results of Operations and Financial Condition UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(D) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of earliest event reported): November 3, 2021 (November 3, 2021) Global Medical REIT Inc. (Exact name of registrant as specified in its charter) Maryland 001-37815 46-4757266 (State or Other Jurisdiction of Incor |
|
| November 3, 2021 |
Exhibit 99.2 Third Quarter 2021 Earnings Supplemental Three and Nine Months Ended September 30, 2021 www.globalmedicalreit.com NYSE: GMRE Corporate Information and Analyst Coverage 2 3Q - 2021| Earnings Supplemental Executive Team Jeffrey Busch Chief Executive Officer, Chairman and President Alfonzo Leon Chief Investment Officer Danica Holley Chief Operating Officer Bob Kiernan Chief Financial Off |
|
| November 3, 2021 |
EX-99.1 2 tm2131832d1ex99-1.htm EXHIBIT 99.1 Exhibit 99.1 Global Medical REIT Announces Third Quarter 2021 Financial Results Completes $163 Million of Acquisitions Year-to-Date Bethesda, MD – November 3, 2021 - (BUSINESS WIRE) - Global Medical REIT Inc. (NYSE: GMRE) (the “Company” or “GMRE”), a net-lease medical office real estate investment trust (REIT) that owns and acquires purpose-built health |
|
| August 6, 2021 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 FORM 10-Q Table of Contents ? ? UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 FORM 10-Q ? ? ? QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 ? For the quarterly period ended June 30, 2021 OR ? ? ? ? TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 ? For the transition period from to . |
|
| August 3, 2021 |
EX-99.2 3 tm2123967d1ex99-2.htm EXHIBIT 99.2 Exhibit 99.2 Second Quarter 2021 Earnings Supplemental Three and Six Months Ended June 30, 2021 www.globalmedicalreit.com NYSE: GMRE Corporate Information and Analyst Coverage 2 2Q - 2021| Earnings Supplemental Executive Team Jeffrey Busch Chief Executive Officer, Chairman and President Alfonzo Leon Chief Investment Officer Danica Holley Chief Operating |
|
| August 3, 2021 |
EX-99.1 2 tm2123967d1ex99-1.htm EXHIBIT 99.1 Exhibit 99.1 Global Medical REIT Announces Second Quarter 2021 Financial Results Completes $140 Million of Acquisitions Year-to-Date Raises $51 Million of Common Equity During the Second Quarter and $201 Million Year-to-Date Bethesda, MD – August 3, 2021 - (BUSINESS WIRE) - Global Medical REIT Inc. (NYSE: GMRE) (the “Company” or “GMRE”), a net-lease med |
|
| August 3, 2021 |
Financial Statements and Exhibits, Results of Operations and Financial Condition UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(D) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of earliest event reported): August 3, 2021 (August 3, 2021) Global Medical REIT Inc. (Exact name of registrant as specified in its charter) Maryland 001-37815 46-4757266 (State or Other Jurisdiction of Incorpora |
|
| June 8, 2021 |
Investor Presentation June 2020 June 2021 Exhibit 99.1 Investor Presentation June 2020 June 2021 Forward - Looking Statements 1 This presentation is for informational purposes only and does not constitute an offer to sell, or a solicitation of offers to purchase, Global Medical REIT Inc . ?s (the ?Company?, or ?GMRE?) securities . The information contained in this presentation does not purport to be complete and should not be relied upon |
|
| June 8, 2021 |
Regulation FD Disclosure, Financial Statements and Exhibits UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(D) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of earliest event reported): June 8, 2021 (June 8, 2021) Global Medical REIT Inc. (Exact name of registrant as specified in its charter) Maryland 001-37815 46-4757266 (State or Other Jurisdiction of Incorporation |
|
| May 28, 2021 |
EX-10.1 2 tm2117932d1ex10-1.htm EXHIBIT 10.1 Exhibit 10.1 GLOBAL MEDICAL REIT INC. 2016 EQUITY INCENTIVE PLAN ARTICLE I DEFINITIONS 1.01. Affiliate “Affiliate” means, with respect to any entity, any other entity, whether now or hereafter existing, which controls, is controlled by, or is under common control with, the first entity (including, but not limited to, joint ventures, limited liability co |
|
| May 28, 2021 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of earliest event reported): May 28, 2021 (May 26, 2021) Global Medical REIT Inc. (Exact name of registrant as specified in its charter) Maryland 001-37815 46-4757266 (State or other jurisdiction of incorporation |
|
| May 25, 2021 |
Regulation FD Disclosure, Financial Statements and Exhibits UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(D) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of earliest event reported): May 25, 2021 (May 25, 2021) Global Medical REIT Inc. (Exact name of registrant as specified in its charter) Maryland 001-37815 46-4757266 (State or Other Jurisdiction of Incorporation |
|
| May 25, 2021 |
Investor Presentation June 2020 May 2021 Exhibit 99.1 Investor Presentation June 2020 May 2021 Forward - Looking Statements 1 This presentation is for informational purposes only and does not constitute an offer to sell, or a solicitation of offers to purchase, Global Medical REIT Inc . ?s (the ?Company?, or ?GMRE?) securities . The information contained in this presentation does not purport to be complete and should not be relied upon a |
|
| May 7, 2021 |
Table of Contents ? ? UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 FORM 10-Q ? ? ? QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 ? For the quarterly period ended March 31, 2021 OR ? ? ? ? TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 ? For the transition period from to . |
|
| May 7, 2021 |
Exhibit 10.5 ? Robert J. Kiernan 6515 Elgin Lane Bethesda, Maryland 20817 ? January 27, 2021 ? Dear Bob: ? First Amendment to Employment Agreement ? This letter memorializes our mutual agreement to amend the Employment Agreement between you and Inter-American Management LLC dated July 9, 2020 (the ?Employment Agreement?) as set forth below. ? Effective as of January 1, 2021 the second sentence of |
|
| May 7, 2021 |
Exhibit 10.4 ? Jeffrey Busch 4515 Foxhall Crest NW Washington, DC 20007 ? January 27, 2021 ? Dear Jeff: ? First Amendment to Employment Agreement ? This letter memorializes our mutual agreement to amend the Employment Agreement between you and Inter-American Management LLC dated July 9, 2020 (the ?Employment Agreement?) as set forth below. ? Effective as of January 1, 2021 the second sentence of S |
|
| May 7, 2021 |
Form of LTIP Award Agreement (Long-Term Time-Based Awards). EX-10.3 4 gmre-20210331xex10d3.htm EX-10.3 Exhibit 10.3 GLOBAL MEDICAL REIT INC. 2016 EQUITY INCENTIVE PLAN LTIP UNIT AWARD AGREEMENT Long-Term Incentive Award (Time-Vesting) Name of Grantee: Number of LTIP Units: Grant Date (Closing Date): March 2, 2021 Final Acceptance Date: , Pursuant to the Global Medical REIT Inc. 2016 Equity Incentive Plan, as amended from time to time (the “Plan”), and the |
|
| May 7, 2021 |
Exhibit 10.6 ? Alfonzo Leon 10401 Strathmore Park Court Unit 405 North Bethesda, Maryland 20852 ? January 27, 2021 ? Dear Alfonzo: ? First Amendment to Employment Agreement ? This letter memorializes our mutual agreement to amend the Employment Agreement between you and Inter-American Management LLC dated July 9, 2020 (the ?Employment Agreement?) as set forth below. ? Effective as of January 1, 20 |
|
| May 7, 2021 |
Form of LTIP Award Agreement (Long-Term Performance Awards). Exhibit 10.2 ? GLOBAL MEDICAL REIT INC. 2016 EQUITY INCENTIVE PLAN ? LTIP UNIT AWARD AGREEMENT Long Term Incentive Award (Performance-Based with Time-Vesting) ? ? ? ? ? ? ? Name of Grantee: ? ? ? Number of LTIP Units: ? ? ? Grant Date (Closing Date): March 2, 2021 ? Final Acceptance Date: ? , ? ? ? ? Pursuant to the Global Medical REIT Inc. 2016 Equity Incentive Plan, as amended from time to time |
|
| May 7, 2021 |
Form of LTIP Award Agreement (Annual Awards). Exhibit 10.1 ? GLOBAL MEDICAL REIT INC. 2016 ANNUAL INCENTIVE PLAN LTIP UNIT VESTING AGREEMENT ? Annual Award (Performance-Based with Time-Vesting) ? ? ? Name of Grantee: [ ] Number of Award LTIP Units: [ ] Grant Date: March 2, 2021 Final Acceptance Date: [ ], 2021 ? Pursuant to the Global Medical REIT Inc. 2016 Equity Incentive Plan, as amended from time to time (the ?Plan?), and the Agreement of |
|
| May 5, 2021 |
EX-99.1 3 tm2115235d1ex99-1.htm EXHIBIT 99.1 Exhibit 99.1 Global Medical REIT Announces First Quarter 2021 Financial Results Raises $150 Million of Common Equity During the First Quarter Completes $101 Million of Acquisitions Year to Date Amends and Restates Credit Facility Bethesda, MD – May 5, 2021 - (BUSINESS WIRE) - Global Medical REIT Inc. (NYSE: GMRE) (the “Company” or “GMRE”), a net-lease m |
|
| May 5, 2021 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(D) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of earliest event reported): May 5, 2021 (May 3, 2021) Global Medical REIT Inc. (Exact name of registrant as specified in its charter) Maryland 001-37815 46-4757266 (State or Other Jurisdiction of Incorporation) |
|
| May 5, 2021 |
Exhibit 99.2 First Quarter 2021 Earnings Supplemental Three Months Ended March 31, 2021 www.globalmedicalreit.com NYSE: GMRE Corporate Information and Analyst Coverage 2 1Q - 2021| Earnings Supplemental Executive Team Jeffrey Busch Chief Executive Officer, Chairman and President Alfonzo Leon Chief Investment Officer Danica Holley Chief Operating Officer Bob Kiernan Chief Financial Officer and Trea |
|
| May 5, 2021 |
Exhibit 10.1 Second Amended and Restated Credit Agreement Dated as of May 3, 2021 among Global Medical REIT L.P., as Borrower the Guarantors from time to time party hereto, the Lenders from time to time party hereto, and JPMorgan Chase Bank, N.A., as Administrative Agent BMO Capital Markets Corp. and Wells Fargo Bank, N.A., as Syndication Agents Citizens Bank, N.A., KeyBank National Association an |
|
| April 16, 2021 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 (Amendment No. ) Filed by the Registrant x Filed by a Party other than the Registrant ? Check the appropriate box: ? Preliminary Proxy Statement ? Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e)(2)) ? Defin |
|
| April 16, 2021 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 (Amendment No. ) Filed by the Registrant x Filed by a Party other than the Registrant ? Check the appropriate box: ? Preliminary Proxy Statement ? Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e)(2)) x Defin |
|
| March 23, 2021 |
Investor Presentation June 2020 March 2021 EX-99.1 2 tm2110560d1ex99-1.htm EXHIBIT 99.1 Exhibit 99.1 Investor Presentation June 2020 March 2021 Forward - Looking Statements 1 This presentation is for informational purposes only and does not constitute an offer to sell, or a solicitation of offers to purchase, Global Medical REIT Inc . ’s (the “Company”, or “GMRE”) securities . The information contained in this presentation does not purport |
|
| March 23, 2021 |
Regulation FD Disclosure, Financial Statements and Exhibits UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of earliest event reported): March 23, 2021 (March 23, 2021) Global Medical REIT Inc. (Exact name of registrant as specified in its charter) Maryland 001-37815 46-4757266 (State or Other Jurisdiction of Incorpora |
|
| March 17, 2021 |
Common Stock Preferred Stock Debt Securities TABLE OF CONTENTS ?Filed Pursuant to Rule 424(b)(5) ?Registration No. 333-239043? Prospectus supplement (To prospectus dated June 17, 2020) 7,500,000 shares Common stock $13.30 per share This is a public offering of shares of common stock of Global Medical REIT Inc. We are selling 7,500,000 shares of common stock. Our common stock is listed on The New York Stock Exchange (the ?NYSE?) under the sym |
|
| March 17, 2021 |
EX-1.1 2 tm2110037d1ex1-1.htm EXHIBIT 1.1 Exhibit 1.1 7,500,000 Shares GLOBAL MEDICAL REIT INC. Common Stock UNDERWRITING AGREEMENT March 16, 2021 J.P. Morgan Securities LLC BMO Capital Markets Corp. Stifel, Nicolaus & Company, Incorporated Wells Fargo Securities, LLC Robert W. Baird & Co. Incorporated As Representatives of the Several Underwriters named in Schedule A hereto c/o J.P. Morgan Securi |
|
| March 17, 2021 |
Entry into a Material Definitive Agreement, Financial Statements and Exhibits UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of earliest event reported): March 17, 2021 (March 16, 2021) Global Medical REIT Inc. (Exact name of registrant as specified in its charter) Maryland 001-37815 46-4757266 (State or Other Jurisdiction of Incorpora |
|
| March 16, 2021 |
TABLE OF CONTENTS The information in this preliminary prospectus supplement is not complete and may be changed. |
|
| March 8, 2021 |
EX-21 2 gmre-20201231xex21.htm EX-21 Exhibit 21 SUBSIDIARIES OF THE REGISTRANT The Company has the following wholly owned subsidiaries as of December 31, 2020: Name State of Organization Global Medical REIT L.P. Delaware Global Medical REIT GP LLC Delaware Inter-American Management LLC Delaware GMR Omaha, LLC Delaware GMR Asheville, LLC Delaware GMR Pittsburgh, LLC Delaware GMR Plano, LLC Delaware |
|
| March 8, 2021 |
Table of Contents ? ? UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D. |
|
| March 3, 2021 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(D) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of earliest event reported): March 3, 2021 (March 2, 2021) Global Medical REIT Inc. (Exact name of registrant as specified in its charter) Maryland 001-37815 46-4757266 (State or Other Jurisdiction of Incorporati |
|
| March 3, 2021 |
Exhibit 99.2 Fourth Quarter 2020 Earnings Supplemental Three and Twelve Months Ended December 31, 2020 www.globalmedicalreit.com NYSE: GMRE Corporate Information and Analyst Coverage 2 4Q - 2020| Earnings Supplemental Jeffrey Busch Chief Executive Officer, Chairman and President Alfonzo Leon Chief Investment Officer Danica Holley Chief Operating Officer Bob Kiernan Chief Financial Officer Jamie Ba |
|
| March 3, 2021 |
EX-99.1 2 tm218601d1ex99-1.htm EXHIBIT 99.1 Exhibit 99.1 Global Medical REIT Announces Fourth Quarter and Year-End 2020 Financial Results Completes $226.5 Million of Acquisitions in 2020 Increases First Quarter 2021 Dividend to $0.205 Per Share Bethesda, MD – March 3, 2021 - (BUSINESS WIRE) - Global Medical REIT Inc. (NYSE: GMRE) (the “Company” or “GMRE”), a net-lease medical office real estate in |
|
| February 10, 2021 |
SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Schedule 13G Under the Securities Exchange Act of 1934 (Amendment No.: 2)* Name of issuer: Global Medical REIT Inc. Title of Class of Securities: REIT CUSIP Number: 37954A204 Date of Event Which Requires Filing of this Statement: December 31, 2020 Check the appropriate box to designate the rule pursuant to which this Schedule is filed: ☒ Ru |
|
| January 8, 2021 |
Investor Presentation Update June 2020 January 2021 Exhibit 99.1 Investor Presentation Update June 2020 January 2021 Forward - Looking Statements 1 This presentation is for informational purposes only and does not constitute an offer to sell, or a solicitation of offers to purchase, Global Medical REIT Inc . ’s (the “Company”, or “GMRE”) securities . The information contained in this presentation does not purport to be complete and should not be re |
|
| January 8, 2021 |
Regulation FD Disclosure, Financial Statements and Exhibits - FORM 8-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(D) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of earliest event reported): January 8, 2021 (January 8, 2021) Global Medical REIT Inc. (Exact name of registrant as specified in its charter) Maryland 001-37815 46-4757266 (State or Other Jurisdiction of Incorpo |
|
| November 13, 2020 |
Regulation FD Disclosure, Financial Statements and Exhibits - FORM 8-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(D) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of earliest event reported): November 13, 2020 (November 12, 2020) Global Medical REIT Inc. (Exact name of registrant as specified in its charter) Maryland 001-37815 46-4757266 (State or Other Jurisdiction of Inc |
|
| November 13, 2020 |
EX-99.1 2 tm2035842d1ex99-1.htm EXHIBIT 99.1 Exhibit 99.1 Investor Presentation June 2020 November 2020 Forward - Looking Statements 1 This presentation is for informational purposes only and does not constitute an offer to sell, or a solicitation of offers to purchase, Global Medical REIT Inc . ’s (the “Company”, or “GMRE”) securities . The information contained in this presentation does not purp |
|
| November 6, 2020 |
Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 FORM 10-Q ☑ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended September 30, 2020 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to . |
|
| November 6, 2020 |
Exhibit 10.8 Execution Version SECOND AMENDED AND RESTATED MANAGEMENT AGREEMENT By and Among GLOBAL MEDICAL REIT L.P., INTER-AMERICAN MANAGEMENT, LLC, and, For the Sole Purpose of Acknowledging that it Consents to the Amendment and Restatement of the Amended and Restated Management Agreement and to the Execution of this Second Amended and Restated Management Agreement, GLOBAL MEDICAL REIT INC. SEC |
|
| November 6, 2020 |
Exhibit 10.7 CONSENT AND THIRD AMENDMENT TO AMENDED AND RESTATED CREDIT AGREEMENT This Consent and Third Amendment to Amended and Restated Credit Agreement (herein, this “Amendment”) is entered into as of July 9, 2020 (the “Third Amendment Effective Date”), among GLOBAL MEDICAL REIT L.P., a Delaware limited partnership (the “Borrower”), GLOBAL MEDICAL REIT INC., a Maryland corporation (the “Parent |
|
| November 4, 2020 |
Financial Statements and Exhibits, Results of Operations and Financial Condition - FORM 8-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(D) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of earliest event reported): November 4, 2020 (November 4, 2020) Global Medical REIT Inc. (Exact name of registrant as specified in its charter) Maryland 001-37815 46-4757266 (State or Other Jurisdiction of Incor |
|
| November 4, 2020 |
Exhibit 99.2 Third Quarter 2020 Earnings Supplemental Three and Nine Months Ended September 30, 2020 www.globalmedicalreit.com NYSE: GMRE Corporate Information and Analyst Coverage 2 3Q - 2020| Earnings Supplemental Jeffrey Busch Chief Executive Officer, Chairman and President Alfonzo Leon Chief Investment Officer Danica Holley Chief Operating Officer Bob Kiernan Chief Financial Officer Jamie Barb |
|
| November 4, 2020 |
Exhibit 99.1 Global Medical REIT Announces Third Quarter 2020 Financial Results Completes $171 Million of Acquisitions to Date in 2020 Internalizes Management Functions in the Quarter Bethesda, MD – November 4, 2020 - (BUSINESS WIRE) - Global Medical REIT Inc. (NYSE: GMRE) (the “Company” or “GMRE”), a net-lease medical office real estate investment trust (REIT) that owns and acquires purpose-built |
|
| September 3, 2020 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of earliest event reported): September 3, 2020 (September 2, 2020) Global Medical REIT Inc. (Exact name of registrant as specified in its charter) Maryland 001-37815 46-4757266 (State or other jurisdiction of inc |
|
| September 3, 2020 |
Global Medical REIT Inc. Board Declares 2020 Third Quarter Common and Preferred Dividends EX-99.1 2 tm2030143d1ex99-1.htm EXHIBIT 99.1 Exhibit 99.1 Global Medical REIT Inc. Board Declares 2020 Third Quarter Common and Preferred Dividends BETHESDA, Md.-(BUSINESS WIRE)- Global Medical REIT Inc. (NYSE: GMRE) (the “Company” or “GMRE”), a net-lease medical office real estate investment trust (REIT) that acquires purpose-built healthcare facilities and leases those facilities to strong healt |
|
| September 1, 2020 |
Regulation FD Disclosure, Financial Statements and Exhibits - FORM 8-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of earliest event reported): September 1, 2020 (September 1, 2020) Global Medical REIT Inc. (Exact name of registrant as specified in its charter) Maryland 001-37815 46-4757266 (State or other jurisdiction of inc |
|
| September 1, 2020 |
Investor Presentation June 2020 September 2020 Exhibit 99.1 Investor Presentation June 2020 September 2020 Forward - Looking Statements 1 This presentation is for informational purposes only and does not constitute an offer to sell, or a solicitation of offers to purchase, Global Medical REIT Inc . ’s (the “Company”, or “GMRE”) securities . The information contained in this presentation does not purport to be complete and should not be relied |
|
| August 17, 2020 |
FORM OF MASTER FORWARD CONFIRMATION EX-99.1 4 tm2027802d1ex99-1.htm EXHIBIT 99.1 Exhibit 99.1 FORM OF MASTER FORWARD CONFIRMATION To: Global Medical REIT Inc. (“Counterparty”) From: [ ] (“Dealer”) [ ] Re: Master Confirmation for Issuer Share Forward Sale Transactions Date: [ ] Ladies and Gentlemen: The purpose of this communication (this “Master Confirmation”) is to set forth the terms and conditions of the transactions to be entere |
|
| August 17, 2020 |
Up to $150,000,000 Common Stock TABLE OF CONTENTS Filed Pursuant to Rule 424(b)(5) Registration No. 333-239043 PROSPECTUS SUPPLEMENT (To prospectus dated June 17, 2020) Up to $150,000,000 Common Stock We and Global Medical REIT L.P. have entered into a sales agreement (the “Sales Agreement”) with BMO Capital Markets Corp., KeyBanc Capital Markets Inc., Stifel, Nicolaus & Company, Incorporated, Truist Securities, Inc., Robert W |
|
| August 17, 2020 |
Exhibit 1.1 GLOBAL MEDICAL REIT INC. UP TO $150,000,000 SHARES OF COMMON STOCK SALES AGREEMENT August 17, 2020 As Agents: BMO CAPITAL MARKETS CORP. 3 Times Square, 25th Floor New York, NY 10036 B. RILEY SECURITIES, INC. 299 Park Avenue, 21st Floor New York, NY 10171 D.A. DAVIDSON & CO. 8 Third Street North Great Falls, MT 59401 ROBERT W. BAIRD & CO. INCORPORATED 777 E. Wisconsin Avenue Milwaukee, |
|
| August 17, 2020 |
Entry into a Material Definitive Agreement, Financial Statements and Exhibits UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of earliest event reported): August 17, 2020 (August 17, 2020) Global Medical REIT Inc. (Exact name of registrant as specified in its charter) Maryland 001-37815 46-4757266 (State or other jurisdiction of incorpo |
|
| August 7, 2020 |
EX-10.1 2 gmre-20200630xex10d1.htm EXHIBIT 10.1 Exhibit 10.1 THIRD AMENDMENT TO THE AGREEMENT OF LIMITED PARTNERSHIP OF GLOBAL MEDICAL REIT L.P. June 16, 2020 Pursuant to Section 11.01 of the Agreement of Limited Partnership of Global Medical REIT L.P. (the “Partnership Agreement”), the General Partner hereby amends the Partnership Agreement as follows: 1. Defined Terms. The following definition o |
|
| August 7, 2020 |
Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 FORM 10-Q ☑ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended June 30, 2020 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to . |
|
| August 5, 2020 |
EX-99.1 2 tm2026580d1ex99-1.htm EXHIBIT 99.1 Exhibit 99.1 Global Medical REIT Announces Second Quarter 2020 Financial Results Completes $132 Million of Acquisitions to Date Internalizes Management Functions Bethesda, MD – August 5, 2020 - (BUSINESS WIRE) - Global Medical REIT Inc. (NYSE: GMRE) (the “Company” or “GMRE”), a net-lease medical office real estate investment trust (REIT) that owns and a |
|
| August 5, 2020 |
Financial Statements and Exhibits, Results of Operations and Financial Condition UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(D) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of earliest event reported): August 5, 2020 (August 5, 2020) Global Medical REIT Inc. (Exact name of registrant as specified in its charter) Maryland 001-37815 46-4757266 (State or Other Jurisdiction of Incorpora |
|
| August 5, 2020 |
Exhibit 99.2 Second Quarter 2020 Earnings Supplemental Three and Six Months Ended June 30, 2020 www.globalmedicalreit.com NYSE: GMRE Corporate Information and Analyst Coverage 2 2Q - 2020| Earnings Supplemental Jeffrey Busch Chief Executive Officer, Chairman and President Alfonzo Leon Chief Investment Officer Danica Holley Chief Operating Officer Bob Kiernan Chief Financial Officer and Treasurer J |
|
| July 28, 2020 |
8-K 1 tm2025782d18k.htm FORM 8-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of earliest event reported): July 28, 2020 (July 24, 2020) Global Medical REIT Inc. (Exact name of registrant as specified in its charter) Maryland 001-37815 46-4757266 (State or |
|
| July 28, 2020 |
Exhibit 99.1 GMRE Announces Exercise of $100 Million Accordion Under its Credit Facility and New Portfolio Milestone of Over $1 Billion of Properties BETHESDA, Md.-(BUSINESS WIRE)- Global Medical REIT Inc. (NYSE: GMRE) (the “Company” or “GMRE”), a net-lease medical office real estate investment trust (REIT) that acquires purpose-built healthcare facilities and leases those facilities to strong hea |
|
| July 24, 2020 |
DEFA14A 1 tm2024696d4defa14a.htm DEFA14A UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 (Amendment No. ) Filed by the Registrant x Filed by a Party other than the Registrant ¨ Check the appropriate box: ¨ Preliminary Proxy Statement ¨ Confidential, for Use of the Commission Only ( |
|
| July 24, 2020 |
DEF 14A 1 tm2024696-3def14a.htm DEF 14A TABLE OF CONTENTS UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 (Amendment No. ) Filed by the Registrant ☒ Filed by a Party other than the Registrant ☐ Check the appropriate box: ☐ Preliminary Proxy Statement ☐ Confidential, for Use of th |
|
| July 9, 2020 |
Exhibit 10.3 Execution Version EMPLOYMENT AGREEMENT This Employment Agreement (“Agreement”) is made and entered into by and between Inter-American Management LLC, a Delaware limited liability company (the “Company”), and Alfonzo Leon (“Employee”) effective as of July 9, 2020 (the “Effective Date”). Background Prior to the Effective Date, the Company served as the external manager of GMR (as define |
|
| July 9, 2020 |
Exhibit 10.4 INTER-AMERICAN MANAGEMENT LLC SEVERANCE PLAN AND SUMMARY PLAN DESCRIPTION 1. Purpose and Effective Date. Inter-American Management LLC, a Delaware limited liability company (the “Company”) has adopted this Severance Plan (this “Plan”) to provide for the potential payment of severance benefits to Eligible Individuals (as defined below) in the event of certain terminations of employment |
|
| July 9, 2020 |
Exhibit 99.2 Investor Presentation June 2020 I Internalization Presentation July 9, 2020 Forward - Looking Statements 1 This presentation is for informational purposes only and does not constitute an offer to sell, or a solicitation of an offer to purchase, Global Medical REIT Inc . ’s (the “Company ”, or “GMRE”) securities . The information contained in this presentation does not purport to be co |
|
| July 9, 2020 |
Exhibit 10.2 Execution Version EMPLOYMENT AGREEMENT This Employment Agreement (“Agreement”) is made and entered into by and between Inter-American Management LLC, a Delaware limited liability company (the “Company”), and Robert J. Kiernan (“Employee”) effective as of July 9, 2020 (the “Effective Date”). Background Prior to the Effective Date, the Company served as the external manager of GMR (as d |
|
| July 9, 2020 |
EX-2.1 2 tm2024392d1ex2-1.htm EXHIBIT 2.1 Exhibit 2.1 EXECUTION VERSION STOCK PURCHASE AGREEMENT dated as of July 9, 2020 by and among Global Medical Reit Inc., ZENSUN ENTERPRISES LIMITED and MR. JEFFREY BUSCH TABLE OF CONTENTS Page Article I DEFINITIONS Section 1.1 Definitions 2 Article II PURCHASE AND SALE Section 2.1 Sale of Shares 14 Section 2.2 Agreement Regarding Liabilities 14 Section 2.3 C |
|
| July 9, 2020 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(D) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of earliest event reported): July 9, 2020 (July 9, 2020) Global Medical REIT Inc. (Exact name of registrant as specified in its charter) Maryland 001-37815 46-4757266 (State or Other Jurisdiction of Incorporation |
|
| July 9, 2020 |
Exhibit 10.6 GLOBAL MEDICAL REIT INC. 2016 EQUITY INCENTIVE PLAN LTIP UNIT VESTING AGREEMENT Name of Grantee: [CEO: Jeffrey Busch][CFO: Robert J. Kiernan][CIO: Alfonzo Leon] Number of LTIP Units: [ ] Grant Date: July 9, 2020 Final Acceptance Date: July 9, 2020 Pursuant to the Global Medical REIT Inc. 2016 Equity Incentive Plan, as amended from time to time (the “Plan”), and the Agreement of Limite |
|
| July 9, 2020 |
Exhibit 10.1 Execution Version EMPLOYMENT AGREEMENT This Employment Agreement (“Agreement”) is made and entered into by and between Inter-American Management LLC, a Delaware limited liability company (the “Company”), and Jeffrey Busch (“Employee”) effective as of July 9, 2020 (the “Effective Date”). Background Prior to the Effective Date, the Company served as the external manager of GMR (as defin |
|
| July 9, 2020 |
Employment Agreement, dated as of December 1, 2016, by and between Allen Webb and IAM. Exhibit 10.5 INTER-AMERICAN MANAGEMENT LLC EMWLOYMENTAGREEMENT Allen E. Webb This Employment Agreement (this "Agreement") is entered into by and between Inter-American Management LLC, a Delaware limited liability company (hereinafter referred to as the "Company"), and Allen E. Webb (hereinafter referred to as the "Executive"), dated and effective as of the Effective Date defmed in Section 1 below. |
|
| July 9, 2020 |
Exhibit 99.1 Global Medical REIT Inc. Announces Internalization Transaction Transaction Preserves Management Continuity and Improves Cost Structure BETHESDA, Md.-(BUSINESS WIRE)- Global Medical REIT Inc. (NYSE: GMRE) (the “Company” or “GMRE”), a net-lease medical office real estate investment trust (REIT) that acquires purpose-built healthcare facilities and leases those facilities to strong healt |
|
| June 15, 2020 |
CORRESP 1 filename1.htm 2 Bethesda Metro Center Suite 440 Bethesda, MD 20814 June 15, 2020 VIA EDGAR AND EMAIL Securities and Exchange Commission 100 F Street, N.E. Washington, D.C. 20549 Attention: Ronald E. Alper Global Medical REIT Inc. Registration Statement on Form S-3 (File No. 333-239043) Dear Mr. Alper: Pursuant to Rule 461 under the Securities Act of 1933, as amended, Global Medical REIT |
|
| June 12, 2020 |
Shareholder Director Nominations 8-K 1 tm2022530d18k.htm FORM 8-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 OR 15(d) of The Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): June 12, 2020 (June 11, 2020) Global Medical REIT Inc. (Exact name of registrant as specified in its charter) Maryland 001-37815 46-4757266 (State or |
|
| June 9, 2020 |
Form of Indenture (for [Subordinated] Debt Securities) (open-ended) EX-4.3 2 tm2021876d1ex4-3.htm EXHIBIT 4.3 Exhibit 4.3 GLOBAL MEDICAL REIT INC. TO , Trustee Indenture (For [Subordinated]* Debt Securities) Dated as of , 20 TABLE OF CONTENTS† Page RECITAL OF THE COMPANY 1 Article I DEFINITIONS AND OTHER PROVISIONS OF GENERAL APPLICATION 1 Section 1.01. Definitions 1 Section 1.02. Compliance Certificates and Opinions 8 Section 1.03. Form of Documents Delivered to |
|
| June 9, 2020 |
S-3 1 tm2021876d1s3.htm FORM S-3 As filed with the Securities and Exchange Commission on June 9, 2020 Registration No. 333- UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM S-3 REGISTRATION STATEMENT UNDER THE SECURITIES ACT OF 1933 GLOBAL MEDICAL REIT INC. (Exact name of registrant as specified in its charter) Maryland 46-4757266 (State or other jurisdiction of incorpo |
|
| June 2, 2020 |
Investor Presentation June 2020 Exhibit 99.1 Investor Presentation June 2020 Forward - Looking Statements 1 This presentation is for informational purposes only and does not constitute an offer to sell, or a solicitation of offers to purchase, Global Medical REIT Inc . ’s (the “Company”, or “GMRE”) securities . The information contained in this presentation does not purport to be complete and should not be relied upon as a basis |
|
| June 2, 2020 |
Regulation FD Disclosure, Financial Statements and Exhibits 8-K 1 tm2021534d18k.htm FORM 8-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 OR 15(d) of The Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): June 2, 2020 (June 2, 2020) Global Medical REIT Inc. (Exact name of registrant as specified in its charter) Maryland 001-37815 46-4757266 (State or ot |
|
| May 8, 2020 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 FORM 10-Q x QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended March 31, 2020 OR ¨ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to . |
|
| May 6, 2020 |
EX-99.1 2 tm2018860d1ex99-1.htm EXHIBIT 99.1 Exhibit 99.1 Global Medical REIT Announces First Quarter 2020 Financial Results Completes $86.9 Million of Acquisitions to Date Collected 96% of April Rent Bethesda, MD – May 6, 2020 - (BUSINESS WIRE) - Global Medical REIT Inc. (NYSE: GMRE) (the “Company” or “GMRE”), a net-lease medical office real estate investment trust (REIT) that owns and acquires p |
|
| May 6, 2020 |
Financial Statements and Exhibits, Results of Operations and Financial Condition 8-K 1 tm2018860d18k.htm FORM 8-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(D) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of earliest event reported): May 6, 2020 (May 6, 2020) Global Medical REIT Inc. (Exact name of registrant as specified in its charter) Maryland 001-37815 46-4757266 (State or Othe |
|
| May 6, 2020 |
Exhibit 99.2 First Quarter 2020 Earnings Supplemental Three Months Ended March 31, 2020 www.globalmedicalreit.com NYSE: GMRE Corporate Information and Analyst Coverage Executive Team Jeffrey Busch Chief Executive Officer, Chairman and President Alfonzo Leon Chief Investment Officer Danica Holley Chief Operating Officer Bob Kiernan Chief Financial Officer and Treasurer Jamie Barber General Counsel |
|
| April 27, 2020 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K/A Amendment No. 1 x ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2019 Or ¨ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File Number: 001-37815 Global |
|
| April 10, 2020 |
Unregistered Sales of Equity Securities UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of earliest event reported): April 10, 2020 (April 9, 2020) Global Medical REIT Inc. (Exact name of registrant as specified in its charter) Maryland 001-37815 46-4757266 (State or Other Jurisdiction of Incorporat |
|
| March 18, 2020 |
Exhibit 99.1 GLOBAL MEDICAL REIT INC. 2016 EQUITY INCENTIVE PLAN LTIP UNIT AWARD AGREEMENT Annual Award (Performance-Based with Time-Vesting) Name of Grantee: Number of LTIP Units: Grant Date (Closing Date): March 17, 2020 Final Acceptance Date: , Pursuant to the Global Medical REIT Inc. 2016 Equity Incentive Plan, as amended from time to time (the “Plan”), and the Agreement of Limited Partnership |
|
| March 18, 2020 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(D) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of earliest event reported): March 18, 2020 (March 17, 2020) Global Medical REIT Inc. (Exact name of registrant as specified in its charter) Maryland 001-37815 46-4757266 (State or Other Jurisdiction of Incorpora |
|
| March 9, 2020 |
Exhibit 21 SUBSIDIARIES OF REGISTRANT The Company has the following wholly owned subsidiaries as of December 31, 2019: Name State of Organization Global Medical REIT L. |
|
| March 9, 2020 |
10-K 1 tm205357-110k.htm FORM 10-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K x ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2019 Or ¨ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File Number: |
|
| March 9, 2020 |
Exhibit 10.30 Second Amendment to Amended and Restated Credit Agreement This Second Amendment to Amended and Restated Credit Agreement (herein, this “Amendment”) is entered into as of October 12, 2019, among Global Medical REIT L.P., a Delaware limited partnership (the “Borrower”), Global Medical REIT Inc., a Maryland corporation (the “Parent” or “Global Medical REIT”), as a Guarantor, the other G |
|
| March 9, 2020 |
EX-4.3 2 tm205357d1ex4-3.htm EXHIBIT 4.3 Exhibit 4.3 DESCRIPTION OF THE REGISTRANT’S SECURITIES REGISTERED PURSUANT TO SECTION 12 OF THE SECURITIES EXCHANGE ACT OF 1934 As of December 31, 2019, Global Medical REIT Inc. (the “Company,” “we,”, “our” and “us” refer solely to Global Medical REIT Inc. and not its subsidiaries) has two classes of securities registered under Section 12 of the Securities |
|
| March 6, 2020 |
GMRE / Global Medical REIT, Inc. / VANGUARD GROUP INC - SCHEDULE 13G/A Passive Investment SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Schedule 13G Under the Securities Exchange Act of 1934 (Amendment No.: 1)* Name of issuer: Global Medical REIT Inc Title of Class of Securities: REIT CUSIP Number: 37954A204 Date of Event Which Requires Filing of this Statement: February 28, 2020 Check the appropriate box to designate the rule pursuant to which this Schedule is filed: ☒ Rul |
|
| March 5, 2020 |
8-K 1 tm2011883-18k.htm FORM 8-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(D) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of earliest event reported): March 5, 2020 (March 3, 2020) Global Medical REIT Inc. (Exact name of registrant as specified in its charter) Maryland 001-37815 46-4757266 (State or |
|
| March 5, 2020 |
Exhibit 99.2 GLOBAL MEDICAL REIT INC. 2016 EQUITY INCENTIVE PLAN LTIP UNIT AWARD AGREEMENT Long-Term Incentive Award (Time-Vesting) Name of Grantee: Number of LTIP Units: Grant Date (Closing Date): March 3, 2020 Final Acceptance Date: , Pursuant to the Global Medical REIT Inc. 2016 Equity Incentive Plan, as amended from time to time (the “Plan”), and the Agreement of Limited Partnership, dated as |
|
| March 5, 2020 |
Exhibit 99.1 GLOBAL MEDICAL REIT INC. 2016 EQUITY INCENTIVE PLAN LTIP UNIT AWARD AGREEMENT Long Term Incentive Award (Performance-Based with Time-Vesting) Name of Grantee: Number of LTIP Units: Grant Date (Closing Date): March 3, 2020 Final Acceptance Date: , Pursuant to the Global Medical REIT Inc. 2016 Equity Incentive Plan, as amended from time to time (the “Plan”), and the Agreement of Limited |
|
| March 4, 2020 |
Exhibit 99.2 Fourth Quarter 2019 Earnings Supplemental Three and Twelve Months Ended December 31, 2019 www.globalmedicalreit.com NYSE: GMRE Corporate Information and Analyst Coverage Executive Team Jeffrey Busch Chief Executive Officer, Chairman and President Alfonzo Leon Chief Investment Officer Danica Holley Chief Operating Officer Bob Kiernan Chief Financial Officer and Treasurer Jamie Barber G |
|
| March 4, 2020 |
Exhibit 99.1 Global Medical REIT Announces Fourth Quarter and Year-End 2019 Financial Results Completes $253.5 Million of Acquisitions in 2019 Bethesda, MD – March 4, 2020 - (BUSINESS WIRE) - Global Medical REIT Inc. (NYSE: GMRE) (the “Company” or “GMRE”), a net-lease medical office real estate investment trust (REIT) that owns and acquires purpose-built healthcare facilities and leases those faci |
|
| March 4, 2020 |
Financial Statements and Exhibits, Results of Operations and Financial Condition, Other Events UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(D) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of earliest event reported): March 4, 2020 (March 3, 2020) Global Medical REIT Inc. (Exact name of registrant as specified in its charter) Maryland 001-37815 46-4757266 (State or Other Jurisdiction of Incorporati |
|
| February 11, 2020 |
GMRE / Global Medical REIT, Inc. / VANGUARD GROUP INC - SCHEDULE 13G Passive Investment SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Schedule 13G Under the Securities Exchange Act of 1934 Name of issuer: Global Medical REIT Inc Title of Class of Securities: REIT CUSIP Number: 37954A204 Date of Event Which Requires Filing of this Statement: December 31, 2019 Check the appropriate box to designate the rule pursuant to which this Schedule is filed: ☒ Rule 13d-1(b) ☐ Rule 13 |
|
| January 17, 2020 |
Unregistered Sales of Equity Securities UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of earliest event reported): January 17, 2020 (January 17, 2020) Global Medical REIT Inc. (Exact name of registrant as specified in its charter) Maryland 001-37815 46-4757266 (State or Other Jurisdiction of Incor |
